- Home
- AVNT vs ACLX Comparison
AVNT vs ACLX Comparison
Compare AVNT & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNT
- ACLX
- Stock Information
- Founded
- AVNT 1927
- ACLX 2015
- Country
- AVNT United States
- ACLX United States
- Employees
- AVNT N/A
- ACLX N/A
- Industry
- AVNT Major Chemicals
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- AVNT Industrials
- ACLX Health Care
- Exchange
- AVNT Nasdaq
- ACLX Nasdaq
- Market Cap
- AVNT 3.4B
- ACLX 3.8B
- IPO Year
- AVNT 1993
- ACLX 2022
- Fundamental
- Price
- AVNT $32.48
- ACLX $68.36
- Analyst Decision
- AVNT Strong Buy
- ACLX Strong Buy
- Analyst Count
- AVNT 5
- ACLX 14
- Target Price
- AVNT $49.40
- ACLX $111.42
- AVG Volume (30 Days)
- AVNT 842.8K
- ACLX 497.6K
- Earning Date
- AVNT 08-01-2025
- ACLX 08-07-2025
- Dividend Yield
- AVNT 3.26%
- ACLX N/A
- EPS Growth
- AVNT N/A
- ACLX N/A
- EPS
- AVNT 1.08
- ACLX N/A
- Revenue
- AVNT $3,238,000,000.00
- ACLX $76,809,000.00
- Revenue This Year
- AVNT $2.77
- ACLX N/A
- Revenue Next Year
- AVNT $4.20
- ACLX $108.81
- P/E Ratio
- AVNT $30.61
- ACLX N/A
- Revenue Growth
- AVNT 3.58
- ACLX N/A
- 52 Week Low
- AVNT $27.86
- ACLX $47.86
- 52 Week High
- AVNT $54.68
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- AVNT 42.32
- ACLX 61.59
- Support Level
- AVNT $32.34
- ACLX $67.58
- Resistance Level
- AVNT $33.63
- ACLX $71.53
- Average True Range (ATR)
- AVNT 0.94
- ACLX 2.12
- MACD
- AVNT -0.00
- ACLX 0.34
- Stochastic Oscillator
- AVNT 29.12
- ACLX 84.40
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.